Skip to main content
    N

    Nkarta Inc (NKTX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.21
    +0.02 (+1.68%)

    Market Cap: $85.23M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    42%(11/26)
    Avg Surprise
    -1.52%

    Upcoming Estimates

    Reports Mar 23, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.44
    Range-$0.50 - -$0.37
    8 analysts
    Revenue Consensus
    N/A
    RangeN/A
    8 analysts
    Reports May 10, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.42
    Range-$0.42 - -$0.42
    1 analysts
    EPS RevisionsNo revisions (30d)
    EPS Estimate DriftChange to current
    90d ago-$0.37-13.5%
    60d ago-$0.36-16.7%
    30d ago-$0.36-16.7%
    7d ago-$0.36-16.7%
    Current-$0.42
    Revenue Consensus
    N/A
    RangeN/A
    2 analysts

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCF-0.88xFCF Yield-113.28%
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-46.60%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio5.79xQuick Ratio5.79x
    Trading Statistics
    Beta1.25Avg Volume1.68M
    52-Week High$3.7252-Week Low$1.10

    Technical Indicators Dashboard

    As of Nov 16, 2026, the price is 44.2% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 30.9, in the neutral range between 30 and 70.

    Moving Averages

    SMA 10$1.46
    SMA 20$1.58
    SMA 50$2.17
    SMA 200$2.49
    EMA 10$1.42
    EMA 20$1.59
    EMA 50$1.97
    EMA 200$2.33

    MACD

    Line: -0.23Signal: -0.22Hist: -0.01

    ADX

    ADX: 45.0+DI: 9.2-DI: 32.9

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down96.0
    PSAR$1.76

    Bollinger Bands

    Upper Band$1.97
    Lower Band$1.19
    %B Position4953%(Upper)
    Band Width0.02

    RSI (14-Day)

    Neutral
    30.9

    Momentum Oscillators

    Stoch %K14.6
    Stoch %D23.8
    Williams %R-85.7
    ROC (10d)-20.4%
    Momentum-0.31
    CCI (20d)-152.2
    MFI (14d)28.4

    Volatility Measures

    ATR (14d)$0.19(15.5%)
    StdDev (20d)0.20
    Hist Vol119.0%(High)

    Volume Flow

    VWAP$1.23
    OBV-3.0M
    AD Line280.5K
    CMF (20d)0.124

    Volume Metrics

    Avg Vol (20d)1.7M
    Vol Ratio0.6x
    VWMA (20d)$1.60

    Pivot Points

    R3$1.50
    R2$1.40
    R1$1.30
    Pivot Point$1.20
    S1$1.09
    S2$1.00
    S3$0.89

    Advanced Oscillators

    TSI-37.58
    Ultimate Osc48.4
    KST-323.82

    Financial Performance

    Related GNG Research

    No research available

    Be the first to write about NKTX

    News

    NKTX Valuation

    GNG's valuation label for NKTX is Undervalued.

    P/FCF
    -0.9x
    P/B
    0.4x
    All NKTX metrics

    NKTX Profitability: Margins, ROIC and FCF

    Nkarta (NKTX) has an operating margin of 0.0% and a net margin of 0.0%.

    Operating margin
    0.0%
    Net margin
    0.0%
    ROE
    -46.6%
    FCF yield
    -113.3%
    NKTX financial statements

    The companies most similar to Nkarta (NKTX) include Mink Therapeutics, NRX Pharmaceuticals and OnKure Therapeutics.

    Sector: Healthcare

    Companies most similar to Nkarta

    NKTX Analyst Ratings

    Nkarta (NKTX) has a Buy consensus from 7 analysts: 7 Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell.

    Consensus
    Buy
    Analysts
    7
    Strong Buy
    1
    Buy
    6
    Hold
    0
    Sell
    0
    Strong Sell
    0
    NKTX stock forecast

    NKTX Bull Case vs Bear Case

    Bull case

    • 100.0% of NKTX's analyst ratings are Buy or Strong Buy.

    NKTX Earnings: Beat Rate and Next Report

    Nkarta (NKTX) beat the EPS estimate in 4 of the last 8 quarters (50.0%). Its next report is expected on Mar 23, 2027.

    Beat rate
    4 of 8 quarters (50.0%)
    Average surprise
    -6.2%
    EPS estimate (fiscal period ending Dec 31, 2026)
    -$0.44
    NKTX earnings history

    NKTX Earnings Date

    NKTX reports Mar 23, 2027. The date is estimated.

    NKTX ETF Holders

    See insider activity

    Updated Nov 5, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology

    Frequently Asked Questions About NKTX

    When does NKTX report earnings?

    Nkarta Inc (NKTX) is expected to report earnings on Mar 23, 2027.

    Does NKTX pay dividends?

    Nkarta Inc (NKTX) does not currently pay a regular dividend.

    What is NKTX's market cap?

    Nkarta Inc (NKTX) has a market capitalization of $85.23M with a current stock price of $1.21.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.